Clinical Trial Update: Pharmacokinetic Study of DA-020 [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 pharmacokinetic study of DA-020 sponsored by Applied Biology, Inc. for chemotherapy-induced alopecia, with the trial not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Alopecia

Drugs mentioned

• DA-020

Snippet

Sponsor: Applied Biology, Inc. | Conditions: Chemotherapy Induced Alopecia, Chemotherapy Side Effects | EARLY_Phase 1 | Status: NOT_YET_RECRUITING